Table 5. The stratification for correlation analysis based on Gli1 expression for the clinicopathological parameters and breast cancer relapse.

	Gli1 low expression (IRS=0-6)		P	Gli1 high expression (IRS=7-12)		P
	Relapsed	Non-relapsed	P	Relapsed	Non-relapsed	P
Age(yeas)
≤35	2	6	0.016	2	2	0.089
≥36	1	39	0.016	40	192	0.089
T-classification
T1	0	21	0.115	8	119	<0.001
T2-4	3	24	0.115	34	75	<0.001
N-classification
N0	0	28	0.172	8	111	<0.001
N1-3	3	17	0.172	34	83	<0.001
Clinical stage
I	0	35	0.003	5	89	<0.001
II-III	3	10	0.003	37	105	<0.001
ER presence
Negative	2	12	0.140	27	74	0.002
Positive	1	33	0.140	15	120	0.002
PR presence
Negative	2	16	0.281	23	97	0.576
Positive	1	29	0.281	19	97	0.576
HER-2 presence
Negative	0	35	0.003	12	48	0.605
Positive	3	10	0.003	30	146	0.605